Here are four insights:
1. Triojection is designed to help inject ozone gas for disc herniation treatment.
2. Dr. Kelekis’ study is the first randomized study comparing an intradiscal ozone procedure to surgery as well as the first to include several countries. Italy, Greece and Switzerland took part in the study.
3. He noted if Triojection yields comparable outcomes to surgery, but limits recovery and complications associated with surgery, it “will be an attractive option for physicians and patients.”
4. Dr. Kelekis is an interventional radiologist at Attikon University Hospital in Athens, Greece.
More articles on devices:
Orthopedic small bone & joint devices market to reach $4B by 2023: 5 highlights
Medtronic, Stryker, NuVasive & more: 7 device company notes
Global wearable medical devices market to grow at 9.5% CAGR through 2021: 3 points
